Prolira News

Prolira secures new investment round

Prolira secures new investment round

Prolira develops the DeltaScan, which enables better and earlier detection of delirium. This way the patient receives necessary treatment timely. Oost NL as fund manager of Topfonds Gelderland, together with Holland Venture and Health Innovations, invested in Prolira. The investment enables further development and commercialization of DeltaScan.
The Dutch press release can be read by clicking on the logo’s/ picture above.

read more
DeltaScan on the Dutch National News

DeltaScan on the Dutch National News

Click on the picture to watch the item of the National 8 o’clock News in the Netherlands (subtitled in English) on 7 March 2018.

University Medical Center Utrecht and company Prolira BV of the Netherlands have developed an innovative device to detect delirium. This mobile monitor, the Deltascan, measures within one minute whether a patient has a delirium. With a delirium, patients suddenly suffer from serious confusion due to a physical cause, such as an infection. One in eight hospital patients, especially the elderly and Intensive Care patients, will experience this.
DeltaScan in UMC Utrecht is the first medical device that shows the probability of delirium.

read more

Prolira B.V.
Padualaan 8
3584 CH, Utrecht
The Netherlands


T. +31 (0)85 06 01 656

error: Content is protected !!